← Eichor
Study identifier: NCT07408479 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance

Condition: Insulin Resistance  ·  Sponsor: Mondelēz International, Inc.

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

To study the potential impact of a diet rich in both Slowly Digestible Starch (SDS) and Resistant Starch (RS), we propose a 2-month nutritional intervention study in which we will study the evolution of carbohydrate variability and metabolism and health-related parameters in 40 volunteers with insulin resistance. Regular sampling of blood, urine and faeces as well as continuous measurement of blood glucose levels will be performed to assess changes in blood glucose levels, insulin resistance, lipid metabolism, inflammation and the composition of the microbiota following the introduction of starch products rich in SDS and RS into the diet.

This description comes directly from the study's public registry record.

Talk to the study team

Julie-Anne Nazare, PhD  ·  +33 4 78 86 29 81  ·  julie-anne.nazare@univ-lyon1.fr

Alexandra Meynier, PhD  ·  +33 1 83 11 45 68  ·  alexandra.meynier@mdlz.com

Always discuss trial participation with your own doctor first.

Locations (1)

Centre de Recherche en Nutrition Humaine Rhone-AlpesLyon, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07408479